PAREA receives €50,000 grant from Entheon Foundation to advance psychedelic-assisted mental health treatments in Europe

We’re delighted to announce that PAREA has received a generous €50,000 grant from the Entheon Foundation, recognising our work to integrate psychedelic-assisted mental health treatments into Europe’s healthcare systems.

This support is especially significant given the increasingly uncertain funding landscape for health NGOs in Europe. With many organisations facing cuts to their operating grants under the EU4Health programme, unrestricted funding like this is crucial for maintaining advocacy efforts and ensuring that independent, forward-looking initiatives can continue at a time when public funding is becoming less reliable 

The grant will strengthen PAREA’s core activities – in particular:

• Strategic advocacy at the EU level, including engagement with the European Parliament and Commission to ensure that psychedelic innovation is embedded into upcoming health strategies and regulatory initiatives.

• Pushing for increased EU research and innovation funding, especially through Horizon Europe and European Brain Health Partnership, to address the urgent need for better mental health treatments.

• Expanding educational and capacity-building efforts, with a focus on clinicians, patient advocates, and national psychedelic societies – helping build a community ready to support safe, effective implementation.

“In just three years, PAREA has catalysed over €10 million in EU funding for psychedelic research and innovation. This grant will help us go even further - strengthening our voice in Brussels and accelerating the transformation of mental health care across Europe.”
                                            — Tadeusz Hawrot, Founder and Executive Director of PAREA

“Supporting PAREA is vital for advancing access to psychedelic-assisted treatments in Europe. By navigating the EU policy landscape, PAREA turns scientific promise into real-world patient access. They are lobbying for one of the most promising therapeutic frontiers.”

                                                               — Laurens de Groot, Partnership Lead, Entheon  

We’re deeply grateful to the Entheon Foundation for their support at this key moment for the field.

About Entheon Foundation

Entheon’s mission is to transform mental healthcare through responsible psychedelic research and innovative legal therapies. It advances science-based approaches and  indigenous holistic practices, together addressing trauma, reducing harm, and promoting profound healing and wholeness in a rapidly changing world.

About PAREA

Psychedelic Access and Research European Alliance - PAREA is a pan-European multistakeholder alliance working to ensure the scientifically grounded, safe, equitable, and people-centred development and integration of psychedelic-assisted care into European health systems — making these treatments accessible and reimbursed.